COVID-19 VACCINATIONS: If, in addition to indemnity for your main employment, you would like cover for delivering COVID-19 Vaccinations please apply for our standalone extension Apply Today

Home  »   Latest NewsPDA Students   »   Student Newsletter – October 2021

Student Newsletter – October 2021

In this edition, read about how MPharm students across the UK are getting involved in the PDA’s #GetVaccinted campaign and find out how to get more involved with the work of the PDA!

Fri 1st October 2021 The PDA

In this months issue:

  • The PDA support student members with exam appeals and academic misconduct
  • Inclusion of LGBT+ education in the MPharm programme
  • The PDA welcomes new and returning pharmacy students
  • Get involved with the PDA
  • Pharmacy Students take part in the PDA’s #GetVaccinated campaign

DOWNLOAD THE October ISSue HERE

thumbnail of Student Newsletter October

 

Not yet a PDA member?

If you have not yet joined the PDA, we encourage you to join today and ask your colleagues to do the same.

Membership is FREE to pharmacy students, trainee pharmacists and for the first three months of being newly qualified.

JOIN THE PDA TODAY

Read about our key member benefits here.

 

 

 

 

 

The Pharmacists' Defence Association is a company limited by guarantee. Registered in England; Company No 4746656.

The Pharmacists' Defence Association is an appointed representative in respect of insurance mediation activities only of
The Pharmacy Insurance Agency Limited which is registered in England and Wales under company number 2591975
and is authorised and regulated by the Financial Conduct Authority (Register No 307063)

The PDA Union is recognised by the Certification Officer as an independent trade union.

Cookie Use

This website uses cookies to help us provide the best user experience. If you continue browsing you are giving your consent to our use of cookies.

General Guidance Resources Surveys PDA Campaigns Regulations Locums Indemnity Arrangements Pre-Regs & Students FAQs Coronavirus (COVID-19)